What We’ve Learned From Transferring “Abnormal” Embryos

In this episode, Dr. Norbert Gleicher discusses what has been learned from transferring embryos identified as chromosomally abnormal during IVF treatment. He explores how these cases have challenged assumptions about embryo selection, implantation potential, and the role of genetic testing in fertility care, providing important insights for patients and clinicians navigating IVF decisions. Brought to you by the Center for Human Reproduction (CHR) on the Upper East Side of New York City. With over 40 years of experience and a history of innovation, CHR has been at the forefront of fertility care since the beginning.  Our founder, Dr. Norbert Gleicher, reported the first successful transvaginal egg retrieval in human history, helping to shape the future of IVF as we know it today. CHR is known for tackling some of the most challenging fertility cases—especially women over 40 and those with diminished ovarian reserve—by offering highly individualized, evidence-based care when others often turn patients away. Our team has published more than 450 peer-reviewed research papers advancing reproductive medicine, reflecting our deep commitment not only to patient care but to the science that drives better outcomes. At CHR, you're never just a number. You're part of a community focused on giving you the personalized support, science, and hope you deserve. Website: www.thechr.com  Facebook: https://www.facebook.com/chrnewyork  Instagram: https://www.instagram.com/chrnewyork/  Linkedin:  https://www.linkedin.com/company/centerforhumanreproduction/  Pinterest: https://www.pinterest.com/CenterforHumanReproduction/  TikTok: https://www.tiktok.com/@chrnewyork